Introduction {#S1}
============

Scrub typhus is an infectious disease, affecting over one million people per year and putting over a billion people at risk in its endemic areas ([@B1]). It is also of military significance and historically has been a leading cause of morbidity and mortality during warfare in the Asia-Pacific region. Patients with scrub typhus often display symptoms, including fever, eschar, headache, rash, pneumonitis, and lymphadenopathy. If diagnosed early, it can be effectively treated with antibiotics, such as doxycycline, delayed treatment; however, can be lethal ([@B2]). Recent outbreaks of scrub typhus in endemic regions and emergence of this disease in non-traditional areas, such as Middle East ([@B3]), South America ([@B4]), and Africa ([@B5]) have emphasized the importance for early diagnosis, disease control, and treatment. Furthermore, no vaccine is currently available, mainly due to strain variations which lead to antigenic heterogeneity and short-term immunity ([@B6]). Insight into the pathogenesis and immunological responses upon *Orientia* infection is paramount not only in understanding its disease progression, but also for developing preventive strategies and novel therapeutics.

Scrub typhus is caused by *Orientia*, an obligate intracellular Gram-negative bacterium transmitted to human by chigger, the larval stage of *Leptotrombidium* mite ([@B7]). Due to the short length of their mouth pieces, chiggers can only reach the epidermis part of the skin ([@B8]), where *Orientia* will enter the host during feeding. In certain percentage of patients, this will elicit strong local immunological reactions leading to the formation of eschars at the bite site. Examination of the composite structure of eschar has suggested that dendritic cells and monocytes/macrophages might be the major early host cells to encounter and harbor *Orientia* ([@B9]). The intracellular bacteria appear to possess the ability to escape from host defense mechanisms and proliferate in these antigen presenting cells including macrophages ([@B10]). In a matter of days, they can disseminate to distant major organs presumably *via* both lymphatic and hematologic circulatory systems.

Numerous animal models have been developed to study scrub typhus, including mice, rats, rabbits, monkeys, etc. ([@B11]). Monkeys are probably the best model, but they are very expensive and require specialized facilities ([@B12]). Mice are most frequently used due to their low cost and ease to handle. Mouse models have been very instrumental in previous studies looking into pathogenesis ([@B13]), vaccine tests ([@B14]) and more recently, into dissecting functions and mechanisms of specific immunological events ([@B15]). However, mouse models could not faithfully mimic the immunological reactions developed by human patients. This is probably due to the fundamental differences between the two species, especially in terms of their immune system makeup ([@B16]). These differences make it difficult to apply knowledge gained with mouse model to humans. Utilizing humanized mice could probably bridge this gap and hold the promise of providing more relevant models for immunological studies and vaccine development ([@B17]).

Earlier generations of human immune system humanized mice showed poor ability to support reconstitution and development of functional human T cells or B cells that are able to secrete IgG ([@B17]). With the introduction of HLA transgenes in the Rag1KO.IL2RγcKO.NOD (NRG) background, the DRAG mice (HLA-DR4.Rag1KO.IL2RγcKO.NOD), and DRAGA mice (HLA-A2.HLA-DR4.Rag1KO.IL2RγcKO.NOD) infused with HLA-matched human hematopoietic stem cells (HSC) have been shown to repopulate the mouse thymus and to reconstitute functional human T cells that support human B cell immunoglobulin class switching and secretion of human IgG ([@B18]--[@B24]). These mice have been used successfully for supporting infection with human pathogens, such as *Plasmodium falciparum* (malaria), HIV, Zika, and influenza A virus, and for analyzing human immune responses upon infection or vaccination ([@B20]--[@B25]). In this study, we successfully established a lethal challenge mouse model in humanized DRAGA mice using footpad inoculation of *Orientia tsutsugamushi* (*O. tsutsugamushi*) (Karp strain). We showed live *Orientia* dissemination into major organs of DRAGA mice, which caused pathological changes in various tissues. More importantly, *Orientia* infection induced human immune responses, including T cell activation, cytokine secretion, and specific antibody development.

Materials and Methods {#S2}
=====================

Generation of Humanized DRAGA Mice and Ethics Statement {#S2-1}
-------------------------------------------------------

DRAGA mice express HLA-A2.1 and HLA-DR0401 molecules on a NRG background and they have been previously described ([@B19], [@B22], [@B24]). HLA-A2.1/HLA-DR0401 positive umbilical cord blood was obtained from the NY Blood Center, Long Island City. Four- to six-week-old DRAGA mice were irradiated (350 rads) and injected intravenously with CD3 T cell-depleted cord blood cells (EasySep Human CD3 Positive Selection Kit, Stem Cell Technologies, \#18051) containing approximately 10^5^ human hematopoietic stem cells (HSCs) (CD34^+^) as measured by fluorescence-activated cell shorting using human CD34 antibodies (clone \#563, BD Biosciences). The procedures for assessing human immune cell reconstitution in peripheral blood have been previously described ([@B18], [@B19]). DRAGA mice were used for 4 months after infusion of human HSCs. All animal procedures reported herein were conducted under IACUC protocols approved by WRAIR/NMRC in compliance with the Animal Welfare Act and in accordance with the principles set forth in the "Guide for the Care and Use of Laboratory Animals," Institute of Laboratory Animals Resources, National Research Council, National Academy Press, 2011.

*Orientia* Inoculum Preparation and Footpad Inoculation {#S2-2}
-------------------------------------------------------

All procedures involved using live *Orientia* was performed in biosafety level 3 (BSL-3) laboratories. *Orientia* (Karp strain) inoculum that was purified previously ([@B14]) was injected into peritoneal cavity of C3H/HeJ mice. Mice were euthanized 7 to 10 days post inoculation. Liver and spleen tissues were homogenized in SYN1 buffer (0.22 M sucrose, 3.6 mM KH~2~PO~4~, 8.6 mM Na~2~HPO~4~, and 4.9 mM glutamic acid) at 1:20 ratio (v/v) and then aliquoted and stored in −80°C freezer until use. Serial dilution of the inoculum were used for intraperitoneal (i.p.) inoculation in CD-1 mice to calculate mLD^50^ ([@B26]) and also quantified by quantitative PCR (qPCR). Inoculation of humanized DRAGA mice was performed by injecting 30 µL inoculum into each footpad (total 60 µL per mouse). Homogenized liver and spleen tissues from non-infected C3H/HeJ mice were injected as controls.

Quantification of *Orientia* {#S2-3}
----------------------------

DNA from bone marrow and major tissues were extracted using blood/tissue DNA kit (Qiagen) and qPCR targeting 47 kDa gene of *Orientia* were performed on a 7500 Fast Real-Time PCR System ([@B27]). Serial dilutions of plasmid containing the amplification fragment sequence ([@B28]) was used to generate standard curves for absolute copy number quantification.

Cell Culture and Bacterial Infection {#S2-4}
------------------------------------

L929 mouse fibroblast cells originally from ATCC were maintained in DMEM media containing 10% FBS, 100 U/mL penicillin, and 100 µg/mL streptomycin. Cells were cultured in incubator at 37°C with 5% CO~2~. Antibiotics were removed from cell culture 24 h prior to infection. Two microliters of inoculum prepared from humanized DRAGA lung tissues were added to a T25 flask containing L929 cells and rocked for 1 h at room temperature and used for immunofluorescent staining on day 7 and day 14.

Immunofluorescent and Immunohistochemistry {#S2-5}
------------------------------------------

Cultured L929 cells or frozen lung and liver sections on glass slides were fixed with 4% paraformaldehyde for 20 min and permeabilized with 0.1% Triton for 5 min at room temperature. They were then blocked in 1% BSA in PBS for 45 min before incubation with scrub typhus patient sera as primary antibody (pooled on day 11 post onset of fever and diluted at 1:1,000) at room temperature for 1 h. The slides were then washed three times (5 min each) in PBS before incubating with a goat anti-human IgG secondary antibody conjugated with Alexa Fluor 568 (Thermo Fisher Scientific). The slides were then washed three times (5 min each) in PBS before being examined under a fluorescent microscope. For immunohistochemistry, animal tissues were fixed in formalin overnight and replaced with 70% ethanol the next day. Paraffin-embedded tissue sections from humanized DRAGA mice post challenge were cut into 5 μm sections and stained with hematoxylin and eosin (H&E).

Immunization {#S2-6}
------------

*Orientia* (Karp stain) inoculum was irradiated at 200 krads for inactivation. Inoculum prepared from uninfected mouse was irradiated as well and used as the control. A total of four immunizations were performed with 2-week intervals. For each immunization, 1 × 10^7^ irradiated bacteria were injected intraperitoneally into each humanized DRAGA mouse.

Antibody Detection and Characterization {#S2-7}
---------------------------------------

Blood from each mouse was collected *via* tail vein. Enzyme-linked immunosorbent assay (ELISA) was used to monitor the development of IgM and IgG specific to 56 kDa recombinant protein ([@B14]). Positive sera were confirmed by immunofluorescence assay on glass slides spotted with whole cell antigen of *Orientia*.

Cytokine Profiling {#S2-8}
------------------

Cytokines and chemokines from humanized DRAGA mouse sera were profiled using Bio-Plex Pro human cytokine 17-plex Assay (Bio-Rad) in a MAGPIX system (Luminex). To ensure mouse cytokines were not interfering with the results, sera from CD-1 mice with or without *Orientia* infection were included as negative controls.

Flow Cytometry {#S2-9}
--------------

Blood (50 µL) from tail vein was collected using heparin-coated capillary tubes, spun down, and erythrocytes were lysed with ACK buffer for 5 min in ice followed by a washed with 1% BSA in PBS. Splenocytes were isolated as previously described ([@B19]). Cells were blocked with anti-mouse Fc block (BD Biosciences) and surface stained with antibodies against human CD3 (\#HIT3a), CD4 (\#SK3), CD8 (\#RPA-T8), CD69 (\#L78), CD62L (\#DREG-56), and CCR7/CD197 (\#150503) from BD Biosciences as described ([@B18]--[@B20]). To evaluate the frequency of human CD4^+^FOXP3^+^ regulatory T cells in spleens of DRAGA mice, cells were first surface stained with human CD3, CD4 antibodies, and then intracellularly stained with a antibody against human FOXP3 (\#236A/E7, Thermo Fisher Scientific) following the manufacturer's instructions. Cells were analyzed in the gated mononuclear FSC/SSC as described previously ([@B19]).

Statistical Analysis {#S2-10}
--------------------

Comparison between two groups of data was performed using Welch's *t*-test in Graphpad Prism 7 software. A *p* value less than 0.05 was considered significant.

Results {#S3}
=======

Footpad Inoculation of *O. tsutsugamushi* Causes Lethality in Humanized DRAGA Mice, But Not in C3H/HeJ Mice {#S3-1}
-----------------------------------------------------------------------------------------------------------

Footpad inoculation has been used in recent mouse models to study inflammatory responses induced by *O. tsutsugamushi* ([@B29]). It is considered as a route that combines intradermal and subcutaneous inoculation ([@B30]), which mimics the natural way of infection *via* chigger bites. Humanized DRAGA mice were inoculated with inoculum (liver/spleen homogenate) containing various amount of *Orientia* ranging from 6 × 10^1^ to 6 × 10^4^ mLD^50^ *via* footpad. For the control group, liver/spleen homogenate that does not contain any bacteria were injected. As illustrated in Figure [1](#F1){ref-type="fig"}A, mice challenged with the highest dose of *Orientia* (6 × 10^4^) group began to show signs of illness such as ruffled fur on day 11 infection and succumbed to infection starting from day 14 post infection. By day 18, all six mice in this group died. However, when inoculated into inbred C3H/HeJ mice, the same high dose did not cause any lethality. This is consistent to what has been reported in inbred BALB/c mice upon footpad inoculation, where the infected BALB/c mice did not die due to infection ([@B29]). Lower *Orientia* challenge doses in humanized DRAGA mice substantially delayed the appearance of sickness and eventual lethality (Figure [1](#F1){ref-type="fig"}A). Over the course of the infection, the body weights of DRAGA mice decreased gradually and this reduction accelerated during the last 4--5 days before death (Figure [1](#F1){ref-type="fig"}B). These data indicated that *Orientia* caused dose-dependent lethality in footpad-inoculated humanized DRAGA mice, but not in C3H/HeJ or in BALB/c mice.

![A lethal model for scrub typhus using humanized DRAGA mice. **(A)** Survival curve of humanized DRAGA and C3H mice inoculated *via* footpad with vehicle control or *Orientia tsutsugamushi* (Karp) of various dosages (mLD^50^): 6 × 10^4^ (DRAGA, *n* = 6; C3H, *n* = 4), 6 × 10^3^ (*n* = 4), 6 × 10^2^ (*n* = 4), and 6 × 10^1^ (*n* = 4). **(B)** The body weight was monitored daily after infection with vehicle control or *Orientia* inoculum at mLD^50^ of 6 × 10^3^ and 6 × 10^1^.](fimmu-09-00816-g001){#F1}

*Orientia* Disseminates Into Major Organs of Humanized DRAGA Mice {#S3-2}
-----------------------------------------------------------------

In order to investigate tissue tropism of *Orientia*, we harvested tissues when humanized DRAGA mice became severely sick after infection. DNA was extracted and the number of *Orientia* was quantified by qPCR. As illustrated in Figure [2](#F2){ref-type="fig"}A, lung was found to contain the most number of bacteria, followed by spleen, liver, kidney, and heart. Brain and bone marrow had the least number of bacteria among the tissues examined. Furthermore, immunofluorescent staining of *Orientia* in frozen tissue sections showed extensive proliferation of bacteria in about 50% of cells in the lung (Figure [2](#F2){ref-type="fig"}B) and to a lesser extent in liver cells (Figure S1 in Supplementary Material). To further test the infectivity of *Orientia* isolated from infected DRAGA mice, tissue homogenate from lung tissue was prepared and used to inoculate L929 cells, a common cell line for culturing *Orientia*. As illustrated in Figures [2](#F2){ref-type="fig"}C,D, L929 cells were infected with *Orientia* as indicated by specific staining (Figure [2](#F2){ref-type="fig"}C) and proliferation of *Orientia* in these cells were quantified by qPCR (Figure [2](#F2){ref-type="fig"}D). These results clearly indicated that humanized DRAGA mice sustain infection with *Orientia*.

![Live *Orientia tsutsugamushi* disseminates into organs of infected humanized DRAGA mice. **(A)** DNA was extracted from various organs of humanized DRAGA mice 2 weeks post infection at 6 × 10^4^ mLD^50^ and *O. tsutsugamushi* was quantified by quantitative PCR (qPCR). **(B)** Immunofluorescence staining showing *O. tsutsugamushi* (red) in lung tissue frozen sections from humanized DRAGA mice 3 weeks post infection at 6 × 10^2^ mLD^50^ (cell nuclei were stained blue with DAPI, magnification, 400×). **(C)** Tissue homogenates were prepared from lung tissue and used to inoculate L929 cells. Immunofluorescence staining was performed to detect the presence of *O. tsutsugamushi* (magnification, 400×) at day 7 and day 14 post inoculation. **(D)** qPCR was used to quantify number of *Orientia* in L929 cells collected in **(C)**.](fimmu-09-00816-g002){#F2}

Pathological Changes in Humanized DRAGA Mice due to *Orientia* Infection {#S3-3}
------------------------------------------------------------------------

Splenomegaly was apparent in infected mice when they became severely sick. The weight of the spleens ranged from 92 to 196 g in the infected group compared to around 80 g in the controls (Figure [3](#F3){ref-type="fig"}A). Histologic findings on tissue sections stained with H&E revealed inflammation and necrosis in the lung, liver, and spleen. Areas of pyogranulomatous and necrotizing splenitis were multifocal to coalescing (Figure [3](#F3){ref-type="fig"}B). There was mild to moderate red pulp necrosis, characterized by cellular debris, neutrophils, and multinucleated giant cells, admixed with increased extramedullary hematopoiesis (EMH) that crowded out normal lymphocytes. The EMH was characterized by abundant hematopoietic precursor cells, megakaryocytes, and intracellular hemosiderin due to increased erythrocyte breakdown (Figures S2A,B in Supplementary Material). Multifocal, miliary, and random necrosis in hepatocytes was clearly identifiable in infected liver associated with fibrinosuppurative and lymphohistiocytic inflammation. Hepatocytes within necrotic foci frequently contained intracellular bacteria, which were confirmed with Gram stains. Infected lungs in humanized DRAGA mice displayed perivasculitis, edema, fibrin, and hemorrhage, and multifocal foci of septal necrosis (Figure [3](#F3){ref-type="fig"}B; Figures S2C,D in Supplementary Material). Interestingly, no histologic changes were noted in the kidney, heart, and brain, where much less amount of bacteria were present as quantified in Figure [2](#F2){ref-type="fig"}A.

![Pathological changes in infected humanized DRAGA mice. **(A)** A representative photo of splenomegaly and average spleen organ weight from control and infected humanized DRAGA mice when they were severely sick. **(B)** Hematoxylin and eosin staining reveals pathological changes in organs of humanized DRAGA mice infected with *Orientia tsutsugamushi* (magnification, 200×).](fimmu-09-00816-g003){#F3}

Strong Th1 but Subdued Th2 Human Cytokine Regulation in Humanized DRAGA Mice Upon *Orientia* Infection {#S3-4}
------------------------------------------------------------------------------------------------------

Cytokines and chemokines are small proteins released by immune cells such as T helper cells and macrophages. They are critical in cell signaling involved in recruiting, regulating immune cells, and modulating inflammatory reactions that act upon pathogen invasions ([@B31]). Using a multiplex assay, we measured cytokine levels in sera collected from control and infected DRAGA mice. Strong Th1-cytokine responses were induced, including IL-2, IL12, IFN-γ, and TNF-α. The average levels of human IFN-γ and TNF-α were over 10-fold in the infected versus the control group. Levels of human IL-12p70 increased by 100-folds in the sera of infected mice, as compared to control (uninfected) mice. However, levels of cytokines for Th2 responses had either modest increase, such as IL-10 or were inhibited, such as IL-13 (Figure [4](#F4){ref-type="fig"}). Serum concentration of IL-4 were either below 0.6 pg/mL or mostly undetectable in the infected or control mice. Other cytokines or chemokines that had significant increase due to *Orientia* infection included IL-8, MIP-1β, MCP-1, IL-1β, IL-6, and G-CSF. An important player for pro-inflammatory Th17 cells, IL-17A, significantly decreased due to the infection. GM-CSF level remained unchanged (Figure [4](#F4){ref-type="fig"}; Figure S3 in Supplementary Material). Consistent with these cytokine profiles, the percentage of cells expressing CD69 and CD62L increased in the spleen for both CD4^+^ and CD8^+^ T cell subsets (Figure S4 in Supplementary Material). Intriguingly, the percentage of human T regulatory cells (Tregs) (CD4^+^FOXP3^+^) significantly increased in the spleen of infected mice as well (2.2 to 7.6%).

![Cytokine and chemokine levels were significantly regulated in sera collected from control (*n* = 4) and infected humanized DRAGA mice (*n* = 7) (\**p* value \< 0.05; \*\**p* value \< 0.01; \*\*\**p* value \< 0.001).](fimmu-09-00816-g004){#F4}

Antigen-Specific Humoral and Cellular Responses Are Developed in Humanized DRAGA Mice Post Immunization {#S3-5}
-------------------------------------------------------------------------------------------------------

Previous studies using serum or cell transfer experiments suggested that both antibody and T-cell responses were important for effective control of *Orientia* growth and provided protection in conventional mouse models by i.p. infection route ([@B32]--[@B34]). In order to evaluate these critical immune functions in humanized DRAGA mice, we immunized them with whole cell *Orientia* inactivated by irradiation (200 krads), which has been shown as effective immunogens previously ([@B35]). In inbred BALB/c mice, specific antibodies were detected 3 weeks after the initial immunization using irradiated *Orienti*a although antibody levels were much lower when compared to viable organisms ([@B36]). ELISA using a recombinant 56 kDa antigen, the dominant surface antigen for *Orientia*, showed that human IgM developed between 2 and 4 weeks after initial immunization and by 10 weeks, both human IgM and IgG were readily detectable in the sera of immunized DRAGA mice. The serum levels of human antibodies reactive to recombinant 56 kDa antigen were quantified based on a standard curve generated from a humanized monoclonal antibody against 56 kDa antigen with known concentrations (Figures [5](#F5){ref-type="fig"}A,B). Furthermore, significant human T cell activation was observed in the blood from immunized DRAGA mice. Percentage of human CD3^+^ T cells more than doubled 8 weeks post initial immunization and this was accompanied with a significant increase of CD4^+^ T cells (\~3-fold) and moderate increase for cytotoxic CD8^+^ T cells (\~2-fold), although it did not reach statistical significance (Figures [5](#F5){ref-type="fig"}C--E).

![Antibody and T cell responses after immunization with irradiated whole cell *Orientia*. Concentrations for IgM **(A)** and IgG **(B)** specifically against 56 kDa protein in serum collected at 2, 6, and 10 weeks after initial immunization. **(C--E)** Percentage of CD3^+^, CD4^+^, and CD8^+^ T cells among total mononuclear cells in blood (\*\**p* value \< 0.01; n.s, not significant).](fimmu-09-00816-g005){#F5}

Discussion {#S4}
==========

Although mouse models have been extensively used for scrub typhus research for many years, there is an urgent need for the development of an animal model that represent the pathology and immune responses of human scrub typhus ([@B6]). Given the vast differences in immune system between mouse and human species ([@B16]) and recent advancements in generating human immune system humanized mice, we aimed to develop a humanized mouse model for scrub typhus. To the best of our knowledge, this is the first of such study in the field. The fact that footpad *Orientia* inoculation leads to lethality in the humanized DRAGA mice, but not in C3H or BALB/c mice ([@B29]) very likely is due to differences of their immune systems. In this study, we have shown that humanized DRAGA mice could be infected by *Orientia via* footpad followed by dissemination into major organs. This caused severe pathological changes in liver, lung, and spleen, but not in organs with less bacterium load, such as brain, heart, and kidney. Th1-dominant human cytokines were induced dramatically in response to the inoculation. Both humoral and cellular adaptive immune responses were observed when humanized DRAGA mice were immunized by irradiated whole cell antigen.

Regulation of cytokines in patient sera has been reported for scrub typhus. Consistent with the intracellular nature of *Orientia* infection, Th1 cytokines, such as IFN-γ, TNF-α, and IL-12 were significantly upregulated while cytokines in Th2 category were much less regulated ([@B37], [@B38]). A very similar pattern of cytokine regulation was observed in our humanized DRAGA mice upon footpad inoculation. These included marked increase of IFN-γ, TNF-α, and IL-12 (Th1 cytokines), and moderate induction of IL-10 and suppression of IL-13 (Th2 cytokines) (Figure [4](#F4){ref-type="fig"}). Serum levels of IL-4, which is responsible for triggering Th2 differentiation, were mostly below the lower detection limit of our assay and thus too low to be determined. IL-10, which is considered to be a Th2 cytokine and anti-inflammatory, was moderately elevated probably due to the fact that in humans both Th1 and Th2 cells can produce IL-10 ([@B39]). Increase of IL-10 was found previously in scrub typhus patients as well ([@B38]). IL-17A, a pro-inflammatory cytokine secreted by Th17 cells was significantly inhibited in the infected DRAGA mice. Recent profiling in scrub typhus patients' sera identified three human chemokines (MCP-1, MIP-1β, and IL-8) that were upregulated during scrub typhus infection and associated with disease severity and mortality ([@B40]). Intriguingly, all three chemokines were dramatically upregulated in our mouse model, suggestive of severe infections in our humanized DRAGA mice. Although investigations into cytokine regulation using conventional mouse models also mimicked human situations to certain extent ([@B41]), they failed to identify important regulators, such as IL-8 (as a marker of scrub typhus disease severity) which is not present in the mouse immune system ([@B42]).

Peripheral T cells in scrub typhus patient blood have been characterized recently ([@B43]), where the percentage of both CD4^+^ and CD8^+^ T cells decreased due to programmed cell death (apoptosis) during the acute phase of infection. Similar reduction of CD4^+^ and CD8^+^ T cells occurred in the spleen of humanized DRAGA mice infected with *Orientia* (Figure S4A in Supplementary Material). More interestingly, as central mediators of immune suppression, human Tregs significantly increased in the spleen upon *Orientia* infection (Figure S4C in Supplementary Material). Stimulation of CD4^+^FOXP3^+^ Tregs upon host/pathogen interaction have been reported in many infectious diseases ([@B44]), and it could have multifold impact on protecting the human host from excessive inflammation and at the same time, serving as a mechanism for pathogens to evade human immune system, which increases the risk of pathogen persistence and chronic disease. Given the severe tissue damages in humanized DRAGA mice (Figure [3](#F3){ref-type="fig"}; Figure S2 in Supplementary Material), increase of Tregs in these tissues might have protective effect for the host. Scrub typhus patients were documented to display significant decrease of Tregs in the peripheral blood ([@B43]) and the authors postulated that this reduction might be due to the migration of Tregs into tissues. It will be interesting to test this hypothesis in our humanized DRAGA mouse models. Functional investigations of Tregs in scrub typhus may provide further insights into its pathogenesis and immune regulation.

T cell responses have been recently shown to be critical in controlling *Orientia* growth and scrub typhus disease progression ([@B45], [@B46]). The marked increase of CD3^+^ T cells, along with increases in both CD4^+^ and CD8^+^ cell populations upon immunization (Figure [5](#F5){ref-type="fig"}), suggests that the humanized DRAGA mice might be suitable for future vaccine or mechanistic studies. In addition, tissue damage caused by necrotic cell death was seen in multiple organs of humanized DRAGA mice post infection (Figure [3](#F3){ref-type="fig"}B; Figure S2 in Supplementary Material). It has been shown recently by Hauptmann et al. that hepatocellular injury and subcapsular necrotic lesions were caused by CD8^+^ T cells ([@B45]). It is very likely that similar lesions observed in the liver tissues (Figure [3](#F3){ref-type="fig"}B) were triggered by CD8^+^ T cells as well. Given the appropriate human T cell and B cell responses after immunization (Figure [5](#F5){ref-type="fig"}), it will be very intriguing to test whether they will offer protection against live *Orientia* challenge.

Through the many failures of translating knowledge gained in conventional mouse models to human clinical studies ([@B16]), the difference between mouse and human (especially with regards to their immune systems) has been increasingly appreciated. For example, formation of granulomas that resemble those observed in human mycobacteriosis was only observed in humanized mice, but not in non-humanized infected controls ([@B47]). Humanized mouse models might bridge this gap ([@B48]). We are in urgent need of mouse models that can better mimic the disease pathology and immunological responses for many human diseases, including scrub typhus. This study represents a successful attempt in this effort. *Orientia* dissemination, disease pathology, cytokine regulations, and adapted immune responses as observed in humanized DRAGA mice make it a valuable tool in future basic and preclinical research for scrub typhus.
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